NCT00313118

Brief Summary

Determination of the mean value of oxidative stress parameters in normals and of the plasma and serum levels, resp. of malondialdehyde, glutathion and superoxide dismutase in healthy subjects.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2006

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2006

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 10, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

April 11, 2006

Completed
4.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2010

Completed
6.3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2016

Completed
Last Updated

March 28, 2017

Status Verified

March 1, 2017

Enrollment Period

4.7 years

First QC Date

April 10, 2006

Last Update Submit

March 27, 2017

Conditions

Healthy

Keywords

oxidative stress parameters

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

healthy persons

You may qualify if:

  • German native speakers
  • Age between 18-80 years
  • Healthy without medication
  • No ophthalmic disease

You may not qualify if:

  • Any history of ocular or systemic diseases or of drug or alcohol abuse
  • Any mentally impaired patient

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Eye Clinic Basel

Basel, Canton of Basel-City, 4031, Switzerland

Location

Biospecimen

Retention: NONE RETAINED

plasma

Study Officials

  • Selim Orgül, MD

    University Hospital, Basel, Switzerland

    STUDY DIRECTOR
0

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof. Dr.

Study Record Dates

First Submitted

April 10, 2006

First Posted

April 11, 2006

Study Start

January 1, 2006

Primary Completion

September 1, 2010

Study Completion

December 1, 2016

Last Updated

March 28, 2017

Record last verified: 2017-03

Data Sharing

IPD Sharing
Will not share

Locations

CH(1)